{"filing":{"accession_number":"0001213900-26-069512","cik":"0002079272","ticker":"LABT","company_name":"Lakewood-Amedex Biotherapeutics Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"ea0294845-8k_lakewood.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026069512/ea0294845-8k_lakewood.htm"},"events":[{"id":11486,"run_id":10083,"accession_number":"0001213900-26-069512","anchor_item_number":"5.03","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"summary":"Lakewood-Amedex Biotherapeutics approved and implemented a 1-for-10 reverse stock split, effective June 19, 2026, which was filed with the Nevada Secretary of State. This structural capital event materially modifies the rights of security holders by reducing share count and affecting trading mechanics and investor holdings.","company_name":"Lakewood-Amedex Biotherapeutics Inc.","ticker":"LABT","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8083,"accession_number":"0001213900-26-069512","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"Item 3.03 discloses a material modification to rights of security holders and incorporates Item 5.03 by reference. Without access to Item 5.03 content, the specific nature of the modification cannot be determined. Item 3.03 modifications are inherently material to security holders, but the event type cannot be precisely classified without knowing whether the modification involves charter/bylaw amendments, preferred stock terms, voting rights, or other structural changes. Classified as other_material pending visibility into Item 5.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T15:42:08.798677+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8084,"accession_number":"0001213900-26-069512","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The disclosure describes a 1-for-10 reverse stock split approved by the Board and filed with Nevada Secretary of State, effective June 19, 2026. While Item 5.03 covers amendments to articles and bylaws, reverse stock splits are structural capital events that materially affect share count, trading mechanics, and investor holdings. This does not fit neatly into the taxonomy's more specific categories (it is not an earnings release, executive change, M\u0026A, restatement, auditor change, going concern, impairment, shareholder vote, delisting, bankruptcy, covenant breach, cybersecurity, dilutive issuance, or litigation), making \"other_material\" the most appropriate classification for a material corporate action.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T15:42:08.798677+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8083,"accession_number":"0001213900-26-069512","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"Item 3.03 discloses a material modification to rights of security holders and incorporates Item 5.03 by reference. Without access to Item 5.03 content, the specific nature of the modification cannot be determined. Item 3.03 modifications are inherently material to security holders, but the event type cannot be precisely classified without knowing whether the modification involves charter/bylaw amendments, preferred stock terms, voting rights, or other structural changes. Classified as other_material pending visibility into Item 5.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T15:42:08.798677+00:00","company_name":"Lakewood-Amedex Biotherapeutics Inc.","ticker":"LABT","filing_date":"2026-06-17"},{"id":8084,"accession_number":"0001213900-26-069512","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The disclosure describes a 1-for-10 reverse stock split approved by the Board and filed with Nevada Secretary of State, effective June 19, 2026. While Item 5.03 covers amendments to articles and bylaws, reverse stock splits are structural capital events that materially affect share count, trading mechanics, and investor holdings. This does not fit neatly into the taxonomy's more specific categories (it is not an earnings release, executive change, M\u0026A, restatement, auditor change, going concern, impairment, shareholder vote, delisting, bankruptcy, covenant breach, cybersecurity, dilutive issuance, or litigation), making \"other_material\" the most appropriate classification for a material corporate action.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T15:42:08.798677+00:00","company_name":"Lakewood-Amedex Biotherapeutics Inc.","ticker":"LABT","filing_date":"2026-06-17"}]}